International Cooperation, Convergence and Harmonization of Pharmaceutical Regulations (eBook)

International Cooperation, Convergence and Harmonization of Pharmaceutical Regulations: A Global Perspective provides the current status of the complex and broad phenomenon of cooperation, convergence and harmonization in the pharmaceutical sector (Part I), thoroughly evaluates its added value and its critical parameters and influencing factors (Part II) in order to recommend actions and measures to support the next steps for cooperation, convergence and harmonization (Part III). All of these recommendations in the book support the establishment of a better coordinated global pharmaceutical system which represents the best realistic alternative to fulfill the objective to establish a global coalition of regulators and to respond to an increased demand to further cooperation in the pharmaceutical sector. This proposed framework, which leverages all of the ongoing positive cooperation initiatives and uses as foundations all of the numerous harmonization projects developed over the years, presents advantages for all stakeholders and would definitively have significant added value to the promotion and protection of global public health. - The status of all major worldwide harmonization and cooperation initiatives (at bilateral, regional, and global levels) - The value of cooperation in the pharmaceutical sector and the driving factors behind harmonization - The proposition of a structure for the global pharmaceutical system and timely recommendations for enhancing international cooperation, as well as further discussion and policy changes in this area

Dr. Pierre-Louis Lezotre specializes in global regulatory strategy, and is recognized for his passion and expertiseon international cooperation, convergence, and harmonization of regulations for pharmaceuticaland biotechnology products. He has worked in different cultural environments and lived inboth Europe and the United States.Dr. Lezotre studied biology (University of Sciences, Saint-Etienne, France)and drug development (University of Pharmacy, Montpellier, France) from1992 to 1998. He then received his Master in Regulatory Sciences in 1999 (Universityof Pharmacy, Lille, France). He also recently completed his PhD in Law with honors (DoctoralSchool of 'Law, Politics and Management,” University of Law, Lille, France).Since 1998, Dr. Lezotre has worked for several international pharmaceutical and biotechnologycompanies, with increasing levels of responsibility. He has served as a regional andthen global regulatory leader for small molecule and biologic/biotech programs in variousstages of research and development (from early discovery to life cycle management). Hesuccessfully led many global regulatory teams in supporting global registrations of majorproducts and numerous development projects in several therapeutic areas, includingdermatology, urology, neurology, and pain. He has been responsible for communicationswith worldwide Drug Regulatory Authorities and has also worked with external partners/companies through co-development agreements and business development programs.Dr. Lezotre has recently been invited to teach courses on international regulation in theRegulatory Sciences programs of the University of Southern California (USC).

---

International Cooperation, Convergence and Harmonization of Pharmaceutical Regulations: A Global Perspective provides the current status of the complex and broad phenomenon of cooperation, convergence and harmonization in the pharmaceutical sector (Part I), thoroughly evaluates its added value and its critical parameters and influencing factors (Part II) in order to recommend actions and measures to support the next steps for cooperation, convergence and harmonization (Part III). All of these recommendations in the book support the establishment of a better coordinated global pharmaceutical system which represents the best realistic alternative to fulfill the objective to establish a global coalition of regulators and to respond to an increased demand to further cooperation in the pharmaceutical sector. This proposed framework, which leverages all of the ongoing positive cooperation initiatives and uses as foundations all of the numerous harmonization projects developed over the years, presents advantages for all stakeholders and would definitively have significant added value to the promotion and protection of global public health. - The status of all major worldwide harmonization and cooperation initiatives (at bilateral, regional, and global levels)- The value of cooperation in the pharmaceutical sector and the driving factors behind harmonization- The proposition of a structure for the global pharmaceutical system and timely recommendations for enhancing international cooperation, as well as further discussion and policy changes in this area